Metabolic syndrome significantly increased the risk of developing paroxysmal atrial fibrillation and/or atrial flutter (OR 2.8) in patients without structural heart diseases.
Cohort (n=592)
No
Effect estimate: OR 2.8 (95% CI 1.3-6.2)
Absolute Event Rate: 9% vs 4%
p-value: p=<0.01
Background Because metabolic syndrome is associated with cardiovascular diseases, its association with the risk of paroxysmal atrial fibrillation (PAF) and/or atrial flutter (PAFL) was examined in the present study. Methods and Results A prospective analysis was performed in 592 consecutive hospitalized patients without obvious structural heart diseases. Sinus rhythm was confirmed by electrocardiography in all patients. PAF/PAFL occurred in 32 (5%) and metabolic syndrome was present in 127 (21%) of the patients enrolled. PAF/PAFL occurred in 12 (9%) of the patients with metabolic syndrome, but only 20 (4%) of patients without metabolic syndrome (p=0.02). Multivariate logistic regression analysis showed that metabolic syndrome was a significant risk factor for PAF/PAFL that was independent of left atrial diameter (>44 mm) or age (>70 years) (odds ratio (OR) 2.8, 95% confidence interval (CI) 1.3-6.2, p<0.01). Among the 5 components of the metabolic syndrome, body mass index ≥25 kg/m2 was the most strongly associated with PAF/PAFL (OR; 3.0, 95% CI 1.2-7.4, p=0.02). Conclusions Metabolic syndrome is highly associated with PAF/PAFL in patients without structural heart diseases and obesity may be an underlying mechanism for the higher prevalence. (Circ J 2007; 71: 252 - 255)
Umetani et al. (Mon,) conducted a cohort in Metabolic syndrome (n=592). Metabolic syndrome vs. Without metabolic syndrome was evaluated on Incidence of paroxysmal atrial fibrillation (PAF) and/or atrial flutter (PAFL) (OR 2.8, 95% CI 1.3-6.2, p=<0.01). Metabolic syndrome significantly increased the risk of developing paroxysmal atrial fibrillation and/or atrial flutter (OR 2.8) in patients without structural heart diseases.